Prothena Corporation plc announced that the company has the potential to receive up to $105 million in cumulative clinical milestone payments by the end of 2026.
Show original
This expected return will be achieved based on the clinical progress of key projects in its R&D pipeline.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreAccording to the latest public documents from the U.S. Securities and Exchange Commission (SEC), Jeffs Brands Ltd (stock code: JFBR) has submitted an application in which an existing shareholder plans to resell up to 1.4 million shares of the company’s common stock.
Invesco and Carmignac short U.S. Treasuries, skeptical about the Fed's rate cut potential
Crypto prices
More
Bitcoin
BTC
$66,981.7
+1.07%
Ethereum
ETH
$1,948.73
+0.17%
Tether USDt
USDT
$0.9997
+0.03%
XRP
XRP
$1.4
-0.68%
BNB
BNB
$606.72
+0.42%
USDC
USDC
$0.9999
+0.07%
Solana
SOL
$82.38
+1.23%
TRON
TRX
$0.2851
+2.34%
Dogecoin
DOGE
$0.09810
-0.10%
Bitcoin Cash
BCH
$560.55
+0.91%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now